Novel anticancer drugs approved in 2020
نویسندگان
چکیده
Cancer is still a major factor threatening human life around the world, and anticancer drugs remain huge unmet clinical need. Here, we reviewed novel including new molecular entities therapeutic biologics approved in US, EU, Japan, China that represent main advances drug research development 2020. Small molecule inhibitors targeting oncogenes, antibodies, antibody conjugates (ADCs) are were More possess target activity overcome resistance anticipated future.
منابع مشابه
Immunoconjugates containing novel maytansinoids: promising anticancer drugs.
The potential of immunoconjugates of cytotoxic drugs for the treatment of cancer has not yet been realized owing to the difficulty of delivering therapeutic concentrations of these drugs to the target cells. In an effort to overcome this problem we have synthesized maytansinoids that have 100- to 1000-fold higher cytotoxic potency than clinically used anticancer drugs. These maytansinoids are l...
متن کاملPhenotypic profiling identifies novel anticancer drugs.
Image analysis of vasculature in a tumor-derived 3D matrix shows high predictive value in discovering angiogenesis inhibitors.
متن کاملMolecular docking study of anti-viral FDA-approved drugs as novel entry and replication Ebola viral inhibitors
Background & Objective: Because of the reported high ability of virulence and the lack of appropriate drug of Ebola virus during the last decades, many investigations have been accomplished regarding discovery and the introduction of anti-Ebola drugs. The aim of this research was the bioinformatical study of entry and replication of Ebola viral inhibition by drug repurposing. Materials & Method...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Drug discoveries and therapeutics
سال: 2021
ISSN: ['1881-7831', '1881-784X']
DOI: https://doi.org/10.5582/ddt.2021.01013